FluoroPharma Medical Inc. Information

FluoroPharma Medical of Montclair, New Jersey, is committed to the discovery, development, and commercialization novel molecular positron emission tomography (PET) agents for the cardiovascular, oncology and neurology arenas. The Company’s broad technology platform was developed in conjunction with leading scientists from Massachusetts General Hospital and Harvard Medical School. Our initial focus is the development of breakthrough PET imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease (CAD). Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries.

View Top Employees from FluoroPharma Medical Inc.

Website	http://www.fluoropharma.com
Ticker	FPMI
Revenue	$152000
Funding	$18.3 million
Employees	2 (1 on RocketReach)
Founded	2003
Address	8 Hillside Ave, Montclair, New Jersey 07042, US
Phone	(973) 744-1565
Fax	(617) 482-3337
Technologies	Network Solutions, Microsoft Project, Teamwork +1 more (view full list)
Industry	Biotechnology, Fluorine chemistry, Pharmaceuticals, Science and Engineering, Positron Emission Tomography, Healthcare, Health Diagnostics, Cardiovascular Disease, Health Care, Discovery, Development And Commercialization, Therapeutics
Competitors	EPIX Pharmaceuticals, ImaginAb, Molecular Targeting Technologies,Inc, Navidea Biopharmaceuticals Limited, Positron Corporation
SIC	SIC Code 38 Companies, SIC Code 384 Companies
NAICS	NAICS Code 334 Companies, NAICS Code 33 Companies